Selected article for: "acute lung injury and lung involvement"

Author: Jongerius, Ilse; Porcelijn, Leendert; van Beek, Anna E.; Semple, John W.; van der Schoot, C. Ellen; Vlaar, Alexander P.J.; Kapur, Rick
Title: The Role of Complement in Transfusion-Related Acute Lung Injury
  • Cord-id: 6iqcxgl0
  • Document date: 2019_10_18
  • ID: 6iqcxgl0
    Snippet: Transfusion-related acute lung injury (TRALI) is a life-threatening complication of acute respiratory distress occurring within 6 hours of blood transfusion. TRALI is one of the leading causes of transfusion-related fatalities and specific therapies are unavailable. Neutrophils are recognized as the major pathogenic cells, whereas T regulatory cells and dendritic cells appear to be important for protection against TRALI. The pathogenesis, however, is complex and incompletely understood. It is fr
    Document: Transfusion-related acute lung injury (TRALI) is a life-threatening complication of acute respiratory distress occurring within 6 hours of blood transfusion. TRALI is one of the leading causes of transfusion-related fatalities and specific therapies are unavailable. Neutrophils are recognized as the major pathogenic cells, whereas T regulatory cells and dendritic cells appear to be important for protection against TRALI. The pathogenesis, however, is complex and incompletely understood. It is frequently postulated that the complement system plays an important role in the TRALI pathogenesis. In this article, we assess the evidence regarding the involvement of complement in TRALI from both human and animal studies. We hypothesize about the potential connection between the complement system and neutrophils in TRALI. Additionally, we draw parallels between TRALI and other acute pulmonary disorders of acute lung injury and acute respiratory distress syndrome regarding the involvement of complement. We conclude that, even though a role for complement in the TRALI pathogenesis seems plausible, studies investigating the role of complement in TRALI are remarkably limited in number and also present conflicting findings. Different types of TRALI animal models, diverse experimental conditions, and the composition of the gastrointestinal microbiota may perhaps all be factors which contribute to these discrepancies. More systematic studies are warranted to shed light on the contribution of the complement cascade in TRALI. The underlying clinical condition of the patient, which influences the susceptibility to TRALI, as well as the transfusion factor (antibody-mediated vs non–antibody-mediated), will be important to take into consideration when researching the contribution of complement. This should significantly increase our understanding of the role of complement in TRALI and may potentially result in promising new treatment strategies.

    Search related documents:
    Co phrase search for related documents
    • acute ali lung injury and lp activation: 1
    • acute ards respiratory distress syndrome and lp activation: 1
    • acute ards respiratory distress syndrome and lp inhibition: 1
    • acute ards respiratory distress syndrome and lp lectin pathway: 1
    • acute respiratory syndrome and lp activation: 1
    • acute respiratory syndrome and lp inhibition: 1
    • acute respiratory syndrome and lp lectin pathway: 1
    • lp activation and lp inhibition: 1
    • lp activation and lp lectin pathway: 1, 2, 3
    • lp inhibition and lp lectin pathway: 1, 2